Aiosyn Mitosis Breast becomes the first AI-powered mitosis detection solution to achieve CE mark certification under IVDR
recent articles
MANCHESTER, N.H., Sept. 30, 2024 /PRNewswire/ -- BioAI, an emerging biotech company applying multimodal artificial intelligence (AI) to novel biomarker discovery, development, and diagnostics, has announced a strategic partnership with...
Utilizing Owkin’s expansive data network and cutting-edge AI, this solution optimizes pre-screening for gBRCA mutations in breast cancer directly from digitized H&E pathology slides The solution aims to improve gBRCA...
Proscia: Life sciences organizations can rapidly build AI algorithms to discover biomarkers, optimize clinical trials, and advance companion diagnostics—powered by the first digital pathology platform to seamlessly integrate foundation...
Mindpeak: Funding strengthens the product development roadmap for AI-powered histopathological assessments, supporting clinical labs and biopharma companies worldwide. HAMBURG, Germany--(BUSINESS WIRE)--Mindpeak, the leader in AI-powered...
Proscia: Pathology at the Speed of Life Streamlining Clinical Development and Maximizing Trial Success with an Enterprise Pathology Platform October 16 11:00 AM — 11:45 AM EDT Register Join us for an exciting discussion about...
From Deciphex on LinkedIn: Big News! 🎉 We’re proud to share that Deciphex has been ranked 8th on LinkedIn’s Top Startups 2024 list for Ireland! This recognition is a testament to our work in advancing digital pathology and...
